Cosmo Pharmaceuticals
C43.F
#5550
Rank
โ‚ฌ0.90 B
Marketcap
55,50ย โ‚ฌ
Share price
1.83%
Change (1 day)
-19.94%
Change (1 year)

Revenue for Cosmo Pharmaceuticals (C43.F)

Revenue in 2023: โ‚ฌ92.78 Million

According to Cosmo Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ94.24 Million. In 2023 the company made a revenue of โ‚ฌ92.78 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cosmo Pharmaceuticals from 2004 to 2023

Annual revenue

Year Revenue Change
2023โ‚ฌ92.78 M-9.12%
2022โ‚ฌ0.10 B56.88%
2021โ‚ฌ65.07 M6.77%
2020โ‚ฌ60.94 M-2.47%
2019โ‚ฌ62.49 M-4.76%
2018โ‚ฌ65.61 M-2.42%
2017โ‚ฌ67.24 M-0.62%
2016โ‚ฌ67.66 M11.64%
2015โ‚ฌ60.6 M-23.85%
2014โ‚ฌ79.59 M41.2%
2013โ‚ฌ56.36 M-5.32%
2012โ‚ฌ59.53 M77.67%
2011โ‚ฌ33.5 M4.55%
2010โ‚ฌ32.05 M20.1%
2009โ‚ฌ26.68 M-21.91%
2008โ‚ฌ34.17 M56.04%
2007โ‚ฌ21.9 M44.48%
2006โ‚ฌ15.15 M-2.24%
2005โ‚ฌ15.5 M40.58%
2004โ‚ฌ11.03 M